ABATIXENT

Active ingredients

The drug ABATIXENT contains one active pharmaceutical ingredient (API):

UNII 3Z9Y7UWC1J - APIXABAN

Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa, and prothrombinase activity. By inhibiting factor Xa, apixaban prevents thrombin generation and thrombus development.

Read about Apixaban

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AF Direct factor Xa inhibitors
Discover more medicines within B01AF02

Authorization and marketing

This brand name is authorized in the following countries: Ecuador Estonia Lithuania Poland

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
EC
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
Identifier(s): 7670-MEE-1222, 7671-MEE-1222
EE
Ravimiamet
Identifier(s): 1804722, 1804733, 1804744, 1804755, 1804766, 1804777, 1804788, 1804799, 1804801, 1804812, 1804823, 1804834, 1804845, 1804856, 1804867, 1804878, 1804889, 1804890, 1804902, 1804913, 1804924, 1804935, 1804946, 1804957
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1093513, 1093514, 1093515, 1093516, 1093517, 1093518, 1093519, 1093520, 1093521, 1093522, 1093523, 1093524, 1093525, 1093526, 1093527, 1093528, 1093529, 1093530, 1093531, 1093532, 1093533, 1093534, 1093535, 1093536, 1093537, 1093538, 1093539, 1093540, 1093541, 1093542, 1093543, 1093544
PL
Rejestru Produktów Leczniczych
Identifier(s): 100428090, 100428108